Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) shares saw an uptick in trading volume on Friday . 1,249,671 shares changed hands during trading, an increase of 151% from the previous session's volume of 497,408 shares.The stock last traded at $13.97 and had previously closed at $14.25.
Analysts Set New Price Targets
RBGLY has been the topic of several recent research reports. Morgan Stanley upgraded shares of Reckitt Benckiser Group from an "equal weight" rating to an "overweight" rating in a research report on Monday, March 16th. Citigroup started coverage on shares of Reckitt Benckiser Group in a research report on Wednesday, January 14th. They issued a "buy" rating for the company. Jefferies Financial Group reaffirmed a "hold" rating on shares of Reckitt Benckiser Group in a report on Wednesday, January 7th. Royal Bank Of Canada downgraded Reckitt Benckiser Group from an "outperform" rating to a "sector perform" rating in a research report on Wednesday, January 14th. Finally, Zacks Research cut Reckitt Benckiser Group from a "hold" rating to a "strong sell" rating in a research report on Tuesday. Two investment analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Reckitt Benckiser Group currently has a consensus rating of "Moderate Buy".
Get Our Latest Report on RBGLY
Reckitt Benckiser Group Stock Down 2.6%
The firm's fifty day moving average price is $15.61 and its 200-day moving average price is $15.74.
Reckitt Benckiser Group Company Profile
(
Get Free Report)
Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.
The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.